Atai backs away from schizophrenia drug after trial failure

The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s wholly owned, psychedelics-focused pipeline.

Customs intercepts four live Pangolins in Ogun – EnviroNews

February 16, 2026

Shettima urges estate developers to uphold standards, professionalism – EnviroNews

February 16, 2026

Source link

Atai backs away from schizophrenia drug after trial failure

Customs intercepts four live Pangolins in Ogun – EnviroNews

Shettima urges estate developers to uphold standards, professionalism – EnviroNews

Top African VC Funds Actively Investing Right Now (2025 Update)

Social housing and the future of Cape Town’s inner-city

Social housing and the future of Cape Town’s inner-city

Leave a Reply Cancel reply

RECOMMENDED NEWS

Dangote regains the title of Africa’s richest man

493 Cases of Sextortion Against Children Linked to Notorious Scam Compounds

General Atomics, CAE Partner to Develop SkyGuardian Training System

Every AI Copyright Lawsuit in the US, Visualized

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Atai backs away from schizophrenia drug after trial failure

Related posts

Top African VC Funds Actively Investing Right Now (2025 Update)

Social housing and the future of Cape Town’s inner-city

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS